| 2022 | OREGOVOMAB AND NON-PLATINUM SINGLE AGENT CHEMOTHERAPY IN PARP INHIBITOR-RESISTANT OVARIAN CANCER PATIENTS NOT CANDIDATE FOR PLATINUM RETREATMENT: A MULTI-COHORT PHASE II STUDY (KGOG 3065/APGOT-OV6) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2019 | Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708)
| BMC CANCER |
| 2018 | Outcomes of Non-High Grade Serous Carcinoma after Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: Single-Institution Experience
| YONSEI MEDICAL JOURNAL |
| 2016 | Outcomes of uterine sarcoma found incidentally after uterus-preserving surgery for presumed benign disease
| BMC CANCER |
| 2022 | PARP inhibitors in ovarian cancer: overcoming resistance with combination strategies
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2019 | Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data
| GYNECOLOGIC ONCOLOGY |
| 2022 | PATIENT-DERIVED ORGANOIDS AS A PRECLINICAL PLATFORM FOR PRECISION MEDICINE IN PATIENTS WITH CERVICAL CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2019 | Patterns of initially overlooked recurrence of peritoneal lesions in patients with advanced ovarian cancer on postoperative multi-detector row CT | ACTA RADIOLOGICA |
| 2020 | Pelvic malakoplakia presenting as endometrial cancer: a case report
| Obstetrics & Gynecology Science |
| 2018 | Perioperative Outcomes of 3-Arm Versus 4-Arm Robotic Radical Hysterectomy in Patients with Cervical Cancer. | JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY |
| 2018 | Periumbilical infiltration of lidocaine with epinephrine for postoperative pain reduction in single-port laparoscopic adnexal surgery | JOURNAL OF OBSTETRICS AND GYNAECOLOGY |
| 2023 | Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D
| JOURNAL FOR IMMUNOTHERAPY OF CANCER |
| 2023 | Phase III MIRASOL (GOG 3045/ENGOT-ov55) study: Initial report of mirvetuximab soravtansine vs. investigator's choice of chemotherapy in platinum-resistant, advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate receptor-alpha expression. | JOURNAL OF CLINICAL ONCOLOGY |
| 2017 | Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2018 | Prediction of perioperative complications after robotic-assisted radical hysterectomy for cervical cancer using the modified surgical Apgar score
| BMC CANCER |
| 2022 | PREDICTION OF SURGICAL OUTCOMES OF INTERVAL DEBULKING SURGERY (IDS) USING IN ADVANCED OVARIAN CANCER: A NOVEL SCORING SYSTEM USING POST-NEOADJUVANT CHEMOTHERAPY (NAC) COMPUTED TOMOGRAPHY (CT) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2017 | Preoperative assessment of lymph node metastasis in endometrial cancer: A Korean Gynecologic Oncology Group study | CANCER |
| 2019 | Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced-stage ovarian cancer
| CANCER MEDICINE |
| 2018 | Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer.
| Obstetrics & Gynecology Science |
| 2016 | Primary and recurrent ovarian high-grade serous carcinomas display similar microRNA expression patterns relative to those of normal ovarian tissue
| ONCOTARGET |
| 2015 | Prognosis of Cervical Cancer in the Era of Concurrent Chemoradiation from National Database in Korea: A Comparison between Squamous Cell Carcinoma and Adenocarcinoma
| PLOS ONE |
| 2019 | Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy | EJSO |
| 2018 | Prognostic significance of supradiaphragmatic lymph node metastasis detected by 18F-FDG PET/CT in advanced epithelial ovarian cancer
| BMC CANCER |
| 2022 | Prognostic value of complete metabolic response on ¹⁸F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2022 | PROPENSITY SCORE-MATCHED COMPARISON OF PERIOPERATIVE OUTCOMES USING DA VINCI XI AND SP SURGICAL SYSTEM IN ENDOMETRIAL CANCER SURGICAL STAGING | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | PROSPECTIVE MULTI-INSTITUTIONAL PHASE III TRIAL OF STANDARD OF CARE THERAPY WITH OR WITHOUT STEROTACTIC ABLATIVE RADIATION THERAPY FOR RECURRENT OVARIAN CANCER (SABR-ROC, KGOG 3064/KROG 2204) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2023 | RAD51/geminin/γH2AX immunohistochemical expression predicts platinum-based chemotherapy response in ovarian high-grade serous carcinoma
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2023 | Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045 | INTERNATIONAL JOURNAL OF CANCER |
| 2022 | RE-VALIDATION OF CHEMOTHERAPY RESPONSE SCORE (CRS) AS A PROGNOSTIC FACTOR IN OVARIAN CANCER: THE EFFECT OF BEVACIZUMAB AND HIPEC ON SURVIVAL | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2019 | Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041) | GYNECOLOGIC ONCOLOGY |
| 2019 | Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study
| JOURNAL OF CLINICAL MEDICINE |
| 2022 | Real-world experience of pembrolizumab and lenvatinib in recurrent endometrial cancer: A multicenter study in Korea | GYNECOLOGIC ONCOLOGY |
| 2020 | Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041)
| CANCERS |
| 2020 | Recommendations for gynecologic cancer care during the COVID-19 pandemic
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2020 | Rethinking Radical Surgery in Interval Debulking Surgery for Advanced-Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy
| JOURNAL OF CLINICAL MEDICINE |
| 2022 | ROBOTIC-ASSISTED RADICAL VAGINAL TRACHELECTOMY | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2023 | Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2017 | Role of preoperative magnetic resonance imaging and histological assessment in identifying patients with a low risk of endometrial cancer: a Korean Gynecologic Oncology Group ancillary study
| ONCOTARGET |
| 2017 | Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery
| ONCOTARGET |
| 2015 | Safety of fertility-sparing surgery in primary mucinous carcinoma of the ovary
| CANCER RESEARCH AND TREATMENT |
| 2022 | Second-line olaparib maintenance therapy is associated with poor response to subsequent chemotherapy in BRCA1/2-mutated epithelial ovarian cancer: A multicentre retrospective study | GYNECOLOGIC ONCOLOGY |
| 2023 | Secondary cytoreductive surgery with and without hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer
| GLAND SURGERY |
| 2023 | Sentinel lymph node biopsy in endometrial cancer: The new norm - A multicentre, international experience | SURGICAL ONCOLOGY-OXFORD |
| 2017 | Sentinel lymph node mapping with indocyanine green in vaginal cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2024 | Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer | CANCER RESEARCH |
| 2023 | Study protocol for prospective multi-institutional phase III trial of standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC)
| BMC CANCER |
| 2017 | Surgical manual of the Korean Gynecologic Oncology Group: ovarian, tubal, and peritoneal cancers
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2017 | Surgical technique for single-port laparoscopy in huge ovarian tumors: SW Kim's technique and comparison to laparotomy
| Obstetrics & Gynecology Science |
| 2020 | Survival outcomes of single-port access laparoscopic radical hysterectomy for early-stage cervical cancer | SURGICAL ONCOLOGY-OXFORD |
| 2024 | The effectiveness of CA125 and HE4 as clinical prognostic markers in epithelial ovarian cancer patients with BRCA mutation
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2017 | The efficacy of systematic lymph node dissection in advanced epithelial ovarian cancer during interval debulking surgery performed after neoadjuvant chemotherapy | JOURNAL OF SURGICAL ONCOLOGY |
| 2020 | The institutional learning curve is associated with survival outcomes of robotic radical hysterectomy for early-stage cervical cancer-a retrospective study
| BMC CANCER |
| 2021 | Time for enhancing government-led primary prevention of cervical cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2018 | Transcatheter Arterial Embolization for Severe Secondary Hemorrhage after Hysterectomy | JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY |
| 2017 | Treatment Preferences for Routine Lymphadenectomy Versus No Lymphadenectomy in Early-Stage Endometrial Cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2016 | Treatment preferences of advanced ovarian cancer patients for adding bevacizumab to first-line therapy | GYNECOLOGIC ONCOLOGY |
| 2016 | Treatment strategies for stage IB cervical cancer: A cost-effectiveness analysis from Korean, Canadian and U.S. perspectives. | GYNECOLOGIC ONCOLOGY |
| 2023 | Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4
| NATURE COMMUNICATIONS |
| 2018 | Two-step sentinel lymph node mapping strategy in endometrial cancer staging using fluorescent imaging: A novel sentinel lymph node tracer injection procedure | SURGICAL ONCOLOGY-OXFORD |
| 2017 | Upregulation of homeobox gene is correlated with poor survival outcomes in cervical cancer
| ONCOTARGET |
